Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer.
Guchelaar NAD, van Eerden RAG, Groenland SL, Doorn LV, Desar IME, Eskens FALM, Steeghs N, van Erp NP, Huitema ADR, Mathijssen RHJ, Koolen SLW; Dutch Pharmacology Oncology Group.
Guchelaar NAD, et al. Among authors: huitema adr.
Biomed Pharmacother. 2022 Sep;153:113393. doi: 10.1016/j.biopha.2022.113393. Epub 2022 Jul 11.
Biomed Pharmacother. 2022.
PMID: 35834987
Free article.